Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation

Carla Olsnes1, Helen Stavang, Karl Brokstad

  • 1Department of Surgical Sciences, Faculty of Medicine, University of Bergen, Bergen, Norway. carla.olsnes@ore.uib.no

BMC Immunology
|January 30, 2009
PubMed
Abstract

Insights

OK-432 stimulates adherent monocytes (MOs) to release immune-signaling chemokines like MCP-1 and MIP-1alpha/beta. This interaction, partly mediated by CD36, explains OK-432

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • OK-432, derived from Streptococcus pyogenes, is clinically used for lymphangiomas and carcinomas.
  • Mononuclear phagocytes (MNPs), including monocytes (MOs), play a role in immune responses.
  • Understanding MNP interaction with OK-432 is crucial for its therapeutic application.

Purpose of the Study:

  • To investigate the in vitro immune response of MNPs to OK-432.
  • To assess the secretion of chemokines (MIP-1alpha/beta, MCP-1) by MOs upon OK-432 stimulation.
  • To elucidate the mechanisms of MNP activation by OK-432, including adherence and specific receptors.

Main Methods:

  • In vitro stimulation of whole blood (WB), PBMCs, and purified MOs with OK-432.
  • Assessment of MIP-1alpha/beta and MCP-1 chemokine secretion.
  • Evaluation of the role of adherence, Syk kinase, PI-3 kinase, and integrins (beta1, beta3, beta2) in the response.
  • Investigation of CD36 and CD18 involvement via antibody blockage.

Main Results:

  • OK-432 induced MCP-1 and MIP-1alpha/beta secretion from MNPs in healthy individuals and HNSCC patients.
  • Minimal MIP-1alpha/beta response was observed upon OK-432 stimulation of whole blood.
  • Adherent MOs showed increased chemokine secretion upon OK-432 stimulation, partly mediated by CD36 and CD18.
  • Syk and PI-3 kinase inhibition showed varied effects on chemokine production.

Conclusions:

  • Adherent human MOs are key producers of MCP-1 and MIP-1alpha/beta in response to OK-432.
  • The CD36 receptor plays a role in modulating MIP-1beta and MCP-1 secretion.
  • OK-432's ability to elicit chemokine release primarily from adhered MOs contributes to its efficacy as a biological response modifying drug.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...